Bridgewater Associates
ACLS icon

Bridgewater Associates’s Axcelis ACLS Stock Holding History

Bridgewater Associates’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,301
Closed -$773K – 1001
2026
Q1 		$773K Buy
+8,301
New +$735K ﹤0.01% 827
2025
Q4 		– Sell
-2,224
Closed -$217K – 1041
2025
Q3 		$217K Buy
+2,224
New +$179K ﹤0.01% 998
2025
Q1 		– Sell
-13,678
Closed -$956K – 668
2024
Q4 		$956K Sell
13,678
-5,367
-28% -$446K ﹤0.01% 512
2024
Q3 		$2M Sell
19,045
-10,448
-35% -$1.22M 0.01% 506
2024
Q2 		$4.19M Buy
+29,493
New +$3.4M 0.02% 388

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Reinhart Partners
Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bridgewater Associates's ACLS Position: Q2 2026 in Review

Bridgewater Associates sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 8,301 shares — an estimated $773K sold.

Bridgewater Associates first reported a position in ACLS in Q2 2024 and held it in 5 quarters. The position peaked at $4.19M in Q2 2024. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Bridgewater Associates reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Bridgewater Associates sold 8,301 Axcelis shares in Q2 2026, an estimated $773K.
  • Bridgewater Associates first reported a position in Axcelis in Q2 2024 and held it in 5 quarters.
  • Bridgewater Associates's Axcelis position peaked at $4.19M in Q2 2024.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.